BACK TO TOP
KSE100
177,382.57
610.39
(0.35%)
KSE100PR
52,412.25
180.35
(0.35%)
ALLSHR
106,289.82
141.72
(0.13%)
KSE30
51,822.39
245.89
(0.48%)
KMI30
255,823.27
1649.18
(0.65%)
BKTI
48,432.52
109.40
(0.23%)
OGTI
35,759.50
-46.88
(-0.13%)
KMIALLSHR
68,759.73
47.95
(0.07%)
PSXDIV20
81,338.92
172.84
(0.21%)
UPP9
64,098.12
696.49
(1.10%)
NITPGI
47,890.77
363.43
(0.76%)
NBPPGI
51,365.48
315.36
(0.62%)
MZNPI
32,172.39
308.64
(0.97%)
JSMFI
40,207.59
-178.06
(-0.44%)
ACI
22,582.84
57.83
(0.26%)
JSGBKTI
75,251.40
95.52
(0.13%)
HBLTTI
19,418.93
19-11-2026
6.32
(0.03%)
MII30
23,217.99
125.17
(0.54%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.62.18
-0.17
(-0.27%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Nov 20, 2026 4:44 PM
REG
DFC
CSF
ODL
Open
62.35
High
62.90
Low
62.04
Volume
75,924
CIRCUIT BREAKER
56.12 — 68.59
DAY RANGE
62.04 — 62.90
52-WEEK RANGE ^
56.11 — 93.99
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
62.35
VAR
12.00
HAIRCUT
15.00
P/E Ratio (TTM) **
17.47
1-Year Change * ^
-23.89%
YTD Change * ^
-26.50%
Last update: Fri, Nov 20, 2026 4:35 PM
Open
62.51
High
62.51
Low
62.20
Close
62.25
Change
-0.45%
LDCP
62.53
Volume
26,500
Total Trades
36
CIRCUIT BREAKER
56.28 — 68.78
DAY RANGE
62.20 — 62.51
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 30, 2026 3:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
62.57
Volume
0
Total Trades
0
CIRCUIT BREAKER
56.31 — 68.83
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited was incorporated as a private limited company in Pakistan under the Repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The company was converted into public unlisted company with effect from October 13, 2020. The Company was listed on Pakistan Stock Exchange on July 09, 2021.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
14,205,717.42
Shares
228,461,200
Face Value
10.00
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Nov 2, 2026Transmission of Quarterly Report for the Period Ended 30 September 2026 View   PDF
Nov 2, 2026Financial Results for the Quarter Ended 30 September 2026 View   PDF
Oct 7, 2026Transmission of Annual Report for the Year Ended 30 June 2026 View   PDF
Oct 5, 2026Financial Results for the Year Ended 30 June 2026 View   PDF
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31st March 2026 View   PDF
DateTitleDocument
Oct 30, 2026Board Meeting In Progress View   
Oct 28, 2026Certified true copy of the resolutions passed in the Annual General Meeting of the Company View   PDF
Oct 23, 2026Board Meeting View   PDF
Oct 7, 2026Notice of Annual General Meeting - Post Publication View   PDF
Oct 6, 2026Notice of Annual General Meeting (Prior to Publication) View   PDF
DateTitleDocument
Oct 30, 2026Material Information View   PDF
Oct 26, 2026Change of Chief Financial Officer View   PDF
Oct 19, 2026Material Information View   PDF
Aug 10, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 7, 2026Chief Financial Officer View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2026202520242023
Sales14,004,60813,153,52112,409,23912,396,983
Profit after Taxation782,597892,039833,464657,984
EPS3.433.903.652.88
Q1 2027Q3 2026Q2 2026Q1 2026
Sales3,363,4593,084,7464,332,5663,370,247
Profit after Taxation233,227275,415404,334203,691
EPS1.021.211.770.89
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2026202520242023
Gross Profit Margin (%)17.4915.3412.7812.16
Net Profit Margin (%)5.596.786.725.31
EPS Growth (%)(12.05)6.8526.74
PEG(1.88)3.140.29

Payouts

Financial Reports